Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lympho...

by Francisco‐Javier Peñalver, José‐Antonio Márquez, Soledad Durán, Pilar Giraldo, Alejandro Martín, Carlos Montalbán, Juan‐Manuel Sancho, María‐José Ramírez, María‐José Terol, Francisco‐Javier Capote, Antonio Gutiérrez, Blanca Sánchez, Andrés López, Antonio Salar, Gil Rodríguez‐Caravaca, Miguel Canales, María‐Dolores Caballero, on behalf of GELTAMO (The Spanish Lymphoma Cooperative Group)
Published 2019-11-01